Mei Li

Mei Li

Auto-generated profile, based on publicly available information

Mei Li

State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan 250012, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2012 in Immunopharmacology and Immunotoxicology
Verified
Journal Article
Closed access
JHJeong Hyejin
Jeong Hyejin
LMLi Mei
Li Mei
SLSeongheon Lee
Seongheon Lee
JCJeong Cheolwon
Jeong Cheolwon
KSKim Seokjai
Kim Seokjai
SKSang Hyun Kwak
Sang Hyun Kwak
The purpose of the present study was to investigate the effect of various opioids including remifentanil, sufentanil, alfentanil and fentanyl on human neutrophil activation induced by lipopolysaccharide (LPS) and to reveal the correlation involving the activation of cytokines and mitogen-activated protein kinases (MAPKs). Neutrophils from human blood were incubated with various concentrations of opioids with LPS. We measured protein levels for tumor necrosis factor-alpha (TNF-α), interleukin (IL)-6 and IL-8 after 4 h incubation period. To clarify the intracellular signaling pathway, we measured the levels of phosphorylation of p38, extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) and c-Jun N-terminal kinase. We also measured the levels for cytokines and MAPKs to reveal the effects of several opioid receptor subtype antagonists on remifentanil with LPS. In the present experiment, only remifentanil could attenuate activation of human neutrophils exposed to LPS. In particular, remifentanil decreased activation of intracellular signaling pathways, including p38 and ERK1/2, and expression of pro-inflammatory cytokines, including TNF-α, IL-6 and IL-8. Especially the decreased activation of cytokines and MAPKs was significantly reverted by a kappa-opioid receptor antagonist on remifentanil with LPS. These results demonstrate that remifentanil can attenuate human neutrophils activations induced by LPS and a kappa-opioid receptor be probably involved in these anti-inflammatory effects mediated by remifentanil.

22 January 2025 in Movement Disorders
Verified
Journal Article
Closed access
ZWZheyi Wang
Zheyi Wang
YSYize Sun
Yize Sun
ZBZetai Bai
Zetai Bai
MLMei Li
Mei Li
DKDeyuan Kong
Deyuan Kong
GWGuanzhao Wu
Guanzhao Wu

5 January 2014 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Open access
PDF file
WKWu Keliang
Wu Keliang
HZHaibin Zhao
Haibin Zhao
HLHui Liu
Hui Liu
MLMei Li
Mei Li
SMShuiying Ma
Shuiying Ma
CZChen Zi-Jiang
Chen Zi-Jiang
To compare the clinical outcomes after day 3 embryo transfer, day 5 single blastocyst transfer (SBT) and frozen-thawed embryo transfer (FET) in high responder patients (>15 retrieved oocytes) undergoing IVF/ICSI treatment. A retrospective analysis of three embryo transfer strategies for the high responder patients in IVF/ICSI cycles. The 1041 high responder patients diagnosed as primary infertility with more than 15 oocytes retrieved were recruited in Day 3 ET group, 308 patients with more than 15 oocytes retrieved first transferred with one blastocyst in SBT group and 425 patients with more than 15 oocytes retrieved in fresh cycle, first transferred with one frozen-thawed blastocyst were assigned in FET group. In the high responder patients, the clinical pregnancy rate after day 5 SBT was significantly lower than that of day 3 ET (43.18 % VS 57.16 %, p < 0.05). In addition, the clinical pregnant rate and implantation rate of FET cycles were significantly higher than SBT cycles (59.06 % vs. 43.18 % and 64.70 % vs. 47.40 %, p < 0.05). The multiple pregnancy rate in FET cycles was markedly lower than that of day 3 ET (2.35 % VS 34.97 %, p < 0.05). FET was the preferable strategy for the high responder patients in IVF/ICSI cycles to obtain both desirable clinical outcome and lower multiple pregnancy rates.

15 June 2022 in Frontiers in Endocrinology
Verified
Journal Article
Open access
NPNan Peng
Nan Peng
SMShuiying Ma
Shuiying Ma
CLCheng Li
Cheng Li
HLHui Liu
Hui Liu
HZHaibin Zhao
Haibin Zhao
MLMei Li
Mei Li
Objective: To explore the clinical application value of half-ICSI treatment for infertility in assisted reproductive technology.Method: A retrospective analysis of 1130 half-ICSI treatments was conducted at the Affiliated Reproductive Hospital of Shandong University from January 2011 to December 2015. Patients with low fertilization rates in previous cycles, primary infertility for >5 years with unexplained reason, or secondary infertility for >5 years without fallopian tube factor were involved in this study. The 2PN rate, high-quality embryo rate, oocyte utilization rate, and clinical outcomes were compared between IVF insemination group (IVF group) and ICSI insemination group (ICSI group). The clinical outcome of half-ICSI insemination treatment, grouped according primary and secondary infertility, was also analyzed.Results: Compared with IVF, ICSI resulted in a significantly higher 2PN rate (74.8% vs. 62.9%), high-quality embryo rate (54.6% vs. 51.7%), and oocyte utilization rate (35.9% vs. 32.8%; P<0.05). Among the 884 fresh-embryo transfer cycles, there were no notable differences in clinical pregnancy rate, live birth rate, or neonatal abnormality rate between the IVF and ICSI groups. Among the 792 primary infertility cycles, ICSI resulted in a significantly higher 2PN rate, high-quality embryo rate, and oocyte utilization rate compared with IVF (75.3% vs. 62.4%, 54.3% vs. 50.8%, 36.4% vs. 32.6%, P<0.05). For the 338 secondary infertility cycles, ICSI resulted in a significantly higher 2PN rate (73.6% vs. 63.9%, P<0.05) compared with IVF, but there were no notable differences in other laboratory results. Moreover, the biochemical pregnancy rate of the ICSI group was significantly lower than for IVF in secondary infertility cycles (49.3% vs. 65.6%; P<0.05). A total of 89 cycles (7.9%) with complete IVF fertilization failure showed a low second polar body (2PB) rate (33.6%) after a 5-h short-time fertilization period, including 34 cycles (3.0%) with no 2PB oocytes observed in the IVF group.Conclusion: ICSI insemination improved laboratory results compared with IVF insemination, however, fresh-embryo transfer of ICSI originated embryos did not improve clinical pregnancy and live birth rates. Rescue ICSI has been successfully applied in clinical IVF insemination to avoid fertilization failure. Therefore, as an extra intervention, it is suggested that ICSI be used judiciously.

20 November 2021 in Lasers in Medical Science
Verified
Journal Article
Closed access
PDF file
CYChangjian Yin
Changjian Yin
LLLian-Jie Li
Lian-Jie Li
SMShuiying Ma
Shuiying Ma
HZHui Zhao
Hui Zhao
LXLihong Xu
Lihong Xu
MLMei Li
Mei Li

19 December 2018 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
JZJingye Zhang
Jingye Zhang
WZWanxia Zhong
Wanxia Zhong
HLHui Liu
Hui Liu
HZHaibin Zhao
Haibin Zhao
MLMei Li
Mei Li
WKWu Keliang
Wu Keliang